ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

Fetal brain and preeclampsia: neurodevelopmental disorder and its potential markers

Murashko A.V., Sidorova I.S., Chilova R.A., Managadze I.J.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), Moscow, Russia

Preeclampsia is a dangerous complication of the perinatal period, a period of neurocorticogenesis, the formation of the neocortex – the principal human brain structure – as well as the correlates of consciousness and sensorimotor signaling, and the structures and functions of higher nervous activity.
This literature review addresses a topical issue: the impact of preeclampsia on fetal neurodevelopment and the search for potential biomarkers of fetal brain damage.
This was a comprehensive analysis of the complex pathophysiological chain of effects that preeclampsia has on the pregnant woman and fetus: ranging from placental dysfunction and impaired integrity and permeability of the blood-brain barrier (BBB), changes in the expression of neuron-specific proteins (NSPs) and the formation of NSP-mediated maternal autoantibodies, to changes in the cytoarchitectonics of the cerebral cortex, neurocorticogenesis and synaptogenesis, and, consequently, the development of a wide spectrum of neurodevelopmental disorders (aautism spectrum disorders, cerebral palsy, attention deficit hyperactivity disorder, cognitive impairment, mental and other disorders).
Conclusion: The presented data offer a new perspective on the phenomenon of preeclampsia as a key process determining fetal brain development and neurodevelopment in general, taking into account factors such as BBB permeability and the role of NSPs as effective diagnostic markers capable of predicting both short-term and long-term outcomes of fetal neurodevelopment.

Authors’ contributions: Murashko A.V., Sidorova I.S., Chilova R.A. – developing the concept and design of the study, editing the text; Managadze I.J. – collection and analysis of literary data, writing the text.
Conflicts of interest: The authors declare that there are no conflicts of interest.
Funding: The study was conducted without sponsorship.
Disclosing AI use: The authors did not use any AI tools to generate the text of the article.
For citation: Murashko A.V., Sidorova I.S., Chilova R.A., Managadze I.D. 
Fetal brain and preeclampsia: neurodevelopmental disorder and its potential markers.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2026; (3): 22-29 (in Russian)
https://dx.doi.org/10.18565/aig.2025.320

Keywords

preeclampsia
neurocorticogenesis
neuron-specific proteins
blood-brain barrier
fetal neurodevelopment

References

  1. Сидорова И.С., Манагадзе И.Д. Современная концепция развития преэклампсии: новые данные. Акушерство и гинекология. 2025; 2: 5-13. [Sidorova I.S., Managadze I.J. Modern concept of the development of preeclampsia: new data. Obstetrics and Gynecology. 2025; (2): 5-13 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.272
  2. Kadic A.S., Kurjak A. Cognitive functions of the fetus. Ultraschall. Med. 2018; 39(2): 181-9. English. https://dx.doi.org/10.1055/s-0043-123469
  3. Fagard J., Esseily R., Jacquey L., O'Regan K., Somogyi E. Fetal origin of sensorimotor behavior. Front. Neurorobot. 2018; 12: 23. https://dx.doi.org/10.3389/fnbot.2018.00023
  4. Mariani B., Nicoletti G., Barzon G., Ortiz Barajas M.C., Shukla M., Guevara R. et al. Prenatal experience with language shapes the brain. Sci. Adv. 2023; 9(47): eadj3524. https://dx.doi.org/10.1126/sciadv.adj3524
  5. Moser J., Schleger F., Weiss M., Sippel K., Semeia L., Preissl H. Magnetoencephalographic signatures of conscious processing before birth. Dev. Cogn. Neurosci. 2021; 49: 100964. https://dx.doi.org/10.1016/j.dcn.2021.100964
  6. Falsaperla R., Collotta A.D., Spatuzza M., Familiari M., Vitaliti G., Ruggieri M. Evidences of emerging pain consciousness during prenatal development: a narrative review. Neurol. Sci. 2022; 43(6): 3523-32. https://dx.doi.org/10.1007/s10072-022-05968-2
  7. Цехмистренко Т.А., Васильева В.А., Обухов Д.К., Шумейко Н.С. Строение и развитие коры большого мозга. М.: Издательство «Спутник+»; 2019. 538 с. [Tsekhmistrenko T.A., Vasilyeva V.A., Obukhov D.K., Shumeyko N.S. Structure and development of the cerebral cortex. Moscow: Publishing house "Sputnik+"; 2019. 538 p. (in Russian)].
  8. Циркин В.И., Трухина С.И., Трухин А.Н. Нейрофизиология: основы нейрофизиологии: учебник для вузов. 2-е изд., испр. и доп. М.: Издательство Юрайт; 2023. 504 с. [Tsirkin V.I., Trukhina S.I., Trukhin A.N. Neurophysiology: fundamentals of neurophysiology: a textbook for universities. 2nd ed., rev. and add. Moscow: Yurayt Publishing House; 2023. 504 p. (in Russian)].
  9. Ismail F.Y., Fatemi A., Johnston M.V. Cerebral plasticity: Windows of opportunity in the developing brain. Eur. J. Paediatr. Neurol. 2017; 21(1): 23-48. https://dx.doi.org/10.1016/j.ejpn.2016.07.007
  10. Lopatina O.L., Panina Y.A., Malinovskaya N.A., Salmina A.B. Early life stress and brain plasticity: from molecular alterations to aberrant memory and behavior. Rev. Neurosci. 2020; 32(2): 131-42. https://dx.doi.org/10.1515/revneuro-2020-0077
  11. Gumusoglu S.B., Chilukuri A.S.S., Santillan D.A., Santillan M.K., Stevens H.E. Neurodevelopmental outcomes of prenatal preeclampsia exposure. Trends Neurosci. 2020; 43(4): 253-68. https://dx.doi.org/10.1016/j.tins.2020.02.003
  12. Kay V.R., Rätsep M.T., Cahill L.S., Hickman A.F., Zavan B., Newport M.E. et al. Effects of placental growth factor deficiency on behavior, neuroanatomy, and cerebrovasculature of mice. Physiol. Genom. 2018; 50(10): 862-75. https://dx.doi.org/10.1152/physiolgenomics.00076.2018
  13. Liu X., Zhao W., Liu H., Kang Y., Ye C., Gu W. et al. Developmental and functional brain impairment in offspring from preeclampsia-like rats. Mol. Neurobiol. 2016; 53(2): 1009-19. https://dx.doi.org/10.1007/s12035-014-9060-7
  14. González-Rojas A., Valencia-Narbona M. Neurodevelopmental disruptions in children of preeclamptic mothers: pathophysiological mechanisms and consequences. Int. J. Mol. Sci. 2024; 25(7): 3632. https://dx.doi.org/10.3390/ijms25073632
  15. Maher G.M., Dalman C., O’Keeffe G.W., Kearney P.M., McCarthy F.P., Kenny L.C. et al. Association between preeclampsia and attention-deficit hyperactivity disorder: a population-based and sibling-matched cohort study. Acta Psychiatr. Scand. 2020; 142(4): 275-83. https://dx.doi.org/10.1111/acps.13162
  16. Kong L., Chen X., Liang Y., Forsell Y., Gissler M., Lavebratt C. Association of preeclampsia and perinatal complications with offspring neurodevelopmental and psychiatric disorders. JAMA Netw. Open. 2022; 5(1): e2145719. https://dx.doi.org/10.1001/jamanetworkopen.2021.45719
  17. Zhao J., Xia L. Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis. Hypertens. Pregnancy. 2022; 41(3-4): 149-58. https://dx.doi.org/10.1080/10641955.20
  18. Maher G.M., O’Keeffe G.W., Dalman C., Kearney P.M., McCarthy F.P., Kenny L.C., Khashan A.S. Association between preeclampsia and autism spectrum disorder: a population-based study. J. Child Psychol. Psychiatry. 2020; 61(2):131-9. doi: 10.1111/jcpp.13127
  19. Zhu Y., Wei S.Y., Fu X.T., Cheng X., Lin X.H. Potential mechanism connecting preeclampsia to autism spectrum disorder in offspring: the role of microglial abnormalities. Front. Biosci. (Landmark). 2025, 30(8): 36412. https://dx.doi.org/10.31083/FBL36412
  20. Кан Н.Е., Леонова А.А., Гусар В.А., Чаговец В.В., Тютюнник В.Л., Волочаева М.В., Солдатова Е.Е., Рыжова К.О., Серебрякова А.П. Критерии оценки дисфункции нейрогенеза плода с ранней задержкой роста с использованием внеклеточных везикул. Акушерство и гинекология. 2025; 3: 56-64. [Kan N.E., Leonova A.A., Gusar V.A., Chagovets V.V., Tyutyunnik V.L., Volochaeva M.V., Soldatova E.E., Ryzhova K.O., Serebriakova A.P. Criteria for assessing fetal neurogenesis dysfunction in early-onset growth restriction using extracellular vesicles. Obstetrics and Gynecology. 2025; (3): 56-64 (in Russian)]. https://dx.doi.org/10.18565/aig.2025.30
  21. Волочаева М.В., Кан Н.Е., Тютюнник В.Л., Леонова А.А., Солдатова Е.Е., Рыжова К.О. Особенности постнатального развития детей с задержкой роста (катамнестическое исследование). Акушерство и гинекология. 2025; 3: 65-71. [Volochaeva M.V., Kan N.E., Tyutyunnik V.L., Leonova A.A., Soldatova E.E., Ryzhova K.O. Postnatal development in children with growth restriction (follow-up study). Obstetrics and Gynecology. 2025; (3): 65-71 (in Russian)]. https://dx.doi.org/10.18565/aig.2025.32
  22. Scott H., Phillips T.J., Stuart G.C., Rogers M.F., Steinkraus B.R., Grant S. et al. Preeclamptic placentae release factors that damage neurons: implications for foetal programming of disease. Neuronal Signal. 2018; 2(4): NS20180139. https://dx.doi.org/10.1042/NS20180139
  23. Sattwika P.D., Schuermans A., Cutler H.R., Alkhodari M., Anggraeni V.Y., Nurdiati D.S. et al. Multi-organ phenotypes of offspring born following hypertensive disorders of pregnancy: a systematic review. J. Am. Heart Assoc. 2024; 13(21): e033617. https://dx.doi.org/10.1161/JAHA.123.033617
  24. Gumusoglu S.B., Chilukuri A.S.S., Hing B.W.Q., Scroggins S.M., Kundu S., Sandgren J.A. et al. Altered offspring neurodevelopment in an arginine vasopressin preeclampsia model. Transl. Psychiatry. 2021; 11(1): 79. https://dx.doi.org/10.1038/s41398-021-01205-0
  25. Wang H., László K.D., Gissler M., Li F., Zhang J., Yu Y. et al. Maternal hypertensive disorders and neurodevelopmental disorders in offspring: a population-based cohort in two nordic countries. Eur. J. Epidemiol. 2021; 36: 519-30. https://dx.doi.org/10.1007/s10654-021-00756-2
  26. Gumusoglu S.B. The role of the placenta-brain axis in psychoneuroimmune programming. Brain Behav. Immun. Health. 2024; 36: 100735. https://doi.org/10.1016/j.bbih.2024.100735
  27. Bucher V., Herrock O.T., Schell S., Visser J., Imberg H., Burke J. et al. Blood-brain barrier injury and neuroinflammation in pre-eclampsia and eclampsia. EBioMedicine. 2025; 116:105742. https://doi.org/10.1016/j.ebiom.2025.105742
  28. Maeda K.J., McClung D.M., Showmaker K.C., Warrington J.P., Ryan M.J., Garrett M.R. et al. Endothelial cell disruption drives increased blood-brain barrier permeability and cerebral edema in the Dahl SS/jr rat model of superimposed preeclampsia. Am. J. Physiol. Heart Circ. Physiol. 2021; 320(2): H535-H548. https://dx.doi.org/10.1152/ajpheart.00383.2020
  29. Bergman L., Torres-Vergara P., Penny J., Wikström J., Nelander M., Leon J. et al. Investigating maternal brain alterations in preeclampsia: the need for a multidisciplinary effort. Curr. Hypertens Rep. 2019; 21(9): 72. https://dx.doi.org/10.1007/s11906-019-0977-0
  30. Bergman L., Hastie R., Zetterberg H., Blennow K., Schell S., Langenegger E. et al. Evidence of neuroinflammation and blood-brain barrier disruption in women with preeclampsia and eclampsia. Cells. 2021; 10(11): 3045. https://dx.doi.org/10.3390/cells10113045
  31. Mahendra V., Clark S.L., Suresh M.S. Neuropathophysiology of preeclampsia and eclampsia: A review of cerebral hemodynamic principles in hypertensive disorders of pregnancy. Pregnancy Hypertens. 2021; 23: 104-11. https://dx.doi.org/10.1016/j.preghy.2020.10.013
  32. Escudero C., Kupka E., Ibañez B., Sandoval H., Troncoso F., Wikström A.K. et al. Brain vascular dysfunction in mothers and their children exposed to preeclampsia. Hypertension. 2023; 80(2): 242-56. https://dx.doi.org/10.1161/HYPERTENSIONAHA.122.19408
  33. Friis T., Wikström A.K., Acurio J., León J., Zetterberg H., Blennow K. et al. Cerebral biomarkers and blood-brain barrier integrity in preeclampsia. Cells. 2022; 11(5): 789. https://dx.doi.org/10.3390/cells11050789
  34. Bergman L., Hastie R., Bokström-Rees E., Zetterberg H., Blennow K., Schell S. et al. Cerebral biomarkers in neurologic complications of preeclampsia. Am. J. Obstet. Gynecol. 2022; 227(2): 298.e1-298.e10. https://dx.doi.org/10.1016/j.ajog.2022.02.036
  35. Liao J., Zhang Z., Huang W., Huang Q., Bi G. Neonatal neuron specific enolase, a sensitive biochemical marker of neuronal damage, is increased in preeclampsia: A retrospective cohort study. Brain Dev. 2020; 42(8): 564-71. https://dx.doi.org/10.1016/j.braindev.2020.04.011
  36. Karampas G., Tzelepis A., Koulouraki S., Lykou D., Metallinou D., Erlandsson L. et al. The utility of maternal blood S100B in women with suspected or established preeclampsia-a systematic review. Biomolecules. 2025;15(6): 840. https://dx.doi.org/10.3390/biom15060840
  37. Wu J., Sheng X., Zhou S., Fang C., Song Y., Wang H. et al. Clinical significance of S100B protein in pregnant woman with early-onset severe preeclampsia. Ginekol. Pol. 2024; 95(9): 711-7. https://dx.doi.org/10.5603/GP.a2021.0126
  38. Wang Y., Guo B., Zhao K., Yang L., Chen T. Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia. Front. Aging Neurosci. 2023; 15: 1148518. https://dx.doi.org/10.3389/fnagi.2023.1148518
  39. Jash S., Banerjee S., Cheng S., Wang B., Qiu C., Kondo A. et al. Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia. Nat. Commun. 2023; 14(1): 5414. https://dx.doi.org/10.1038/s41467-023-41144-6
  40. Andersson M., Oras J., Thörn S.E., Karlsson O., Kälebo P., Zetterberg H. et al. Signs of neuroaxonal injury in preeclampsia-A case control study. PLoS One. 2021; 16(2): e0246786. https://dx.doi.org/10.1371/journal.pone.0246786
  41. Gu X., Rana S., Ngo L., Mueller A., Dillon S., Salahuddin S. et al. Plasma markers of neurological injury are elevated in preeclampsia. Pregnancy Hypertens. 2025; 42: 101265. https://dx.doi.org/10.1016/j.preghy.2025.101265
  42. Vinci L., Ravarino A., Fanos V., Naccarato A.G., Senes G., Gerosa C. et al. Immunohistochemical markers of neural progenitor cells in the early embryonic human cerebral cortex. Eur. J. Histochem. 2016; 60(1): 2563. https://dx.doi.org/10.4081/ejh.2016.2563
  43. Сидорова И.С., Манагадзе И.Д. Современные представления о преэклампсии с учетом роли нейронспецифических белков головного мозга плода. Акушерство и гинекология. 2025; 1: 5-11. [Sidorova I.S., Managadze I.J. Current understanding of preeclampsia with regard to the role of fetal brain neuron-specific proteins. Obstetrics and Gynecology. 2025; (1): 5-11 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.221
  44. Jurewicz E., Filipek A. Ca2+-binding proteins of the S100 family in preeclampsia. Placenta. 2022; 127: 43-51. https://dx.doi.org/10.1016/j.placenta.2022.07.018
  45. Evers K.S., Atkinson A., Barro C., Fisch U., Pfister M., Huhn E.A. et al. Neurofilament as neuronal injury blood marker in preeclampsia. Hypertension. 2018; 71(6): 1178-84. https://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10314
  46. Medegan Fagla B., Buhimschi I.A. Protein misfolding in pregnancy: current insights, potential mechanisms, and implications for the pathogenesis of preeclampsia. Molecules. 2024; 29(3): 610. https://dx.doi.org/10.3390/molecules29030610
  47. Bergman L., Zetterberg H., Kaihola H., Hagberg H., Blennow K., Åkerud H. Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study. PLoS One. 2018; 13(5): e0196025. https://dx.doi.org/10.1371/journal.pone.0196025
  48. Ayaydın H., Kirmit A., Çelik H., Akaltun İ., Koyuncu İ., Bilgen Ulgar Ş. High serum levels of serum 100 beta protein, neuron-specific enolase, tau, active caspase-3, M30 and M65 in children with autism spectrum disorders. Clin. Psychopharmacol. Neurosci. 2020;18(2): 270-8. https://dx.doi.org/10.9758/cpn.2020.18.2.270
  49. Bagnall-Moreau C., Spielman B., Brimberg L. Maternal brain reactive antibodies profile in autism spectrum disorder: an update. Transl. Psychiatry. 2023; 13(1): 37. https://dx.doi.org/10.1038/s41398-023-02335-3
  50. Krakowiak P., Walker C.K., Tancredi D., Hertz-Picciotto I., Van de Water J. Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions. Autism Res. 2017; 10(1): 89-98. https://dx.doi.org/10.1002/aur.1657

Received 07.11.2025

Accepted 24.03.2026

About the Authors

Andrey V. Murashko, Dr. Med. Sci., Professor, Professor at the Department of Obstetrics and Gynecology No. 1, N.V. Sklifosofsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bld. 2,
+7(499)248-67-29, murashkoa@mail.ru, https://orcid.org/0000-0003-0663-2909
Iraida S. Sidorova, Dr. Med. Sci., Professor, Academician of the RAS, Merited Scholar of the Russian Federation, Merited Doctor of the Russian Federation, Professor
at the Department of Obstetrics and Gynecology No. 1, N.V. Sklifosofsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University,
Ministry of Health of the Russian Federation (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bld. 2, +7(499)248-67-29, sidorovais@yandex.ru,
https://orcid.org/0000-0003-2209-8662
Raisa A. Chilova, Dr. Med. Sci., Head of the Department of Obstetrics and Gynecology No. 1, N.V. Sklifosofsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bld. 2, +7(499)248-67-29, chilova_r_a@staff.sechenov.ru, https://orcid.org/0000-0001-6331-3109
Ioanna J. Managadze, Resident and PhD student at the Department of Obstetrics and Gynecology No. 1, N.V. Sklifosofsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bld. 2, +7(499)248-67-29, ktb1966@mail.ru, https://orcid.org/0000-0001-8745-9372
Corresponding author: Ioanna J. Managadze, ktb1966@mail.ru

Similar Articles